Prelude Capital Management, LLC Adaptive Biotechnologies Corp Transaction History

Prelude Capital Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $94,545 - $157,389	-18,648 Reduced 58.63%	13,156 $71,000
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $22,593 - $32,046	-3,650 Reduced 10.3%	31,804 $213,000
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $99,652 - $129,165	12,776 Added 56.34%	35,454 $313,000
Q4 2022 Feb 14, 2023	SELL	$6.26 - $9.34 $501,663 - $748,488	-80,138 Reduced 77.94%	22,678 $173,000
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $55,841 - $108,847	8,591 Added 9.12%	102,816 $732,000
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $326,124 - $750,596	-50,957 Reduced 35.1%	94,225 $762,000
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $1.47 Million - $4.2 Million	145,182 New	145,182 $2.02 Million
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $163,328 - $239,119	-6,489 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $40,857 - $54,263	-1,361 Reduced 17.34%	6,489 $221,000
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $420,245 - $581,587	-13,043 Reduced 62.43%	7,850 $321,000
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $588,000 - $1.07 Million	15,781 Added 308.71%	20,893 $841,000
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $168,562 - $245,185	3,745 Added 273.96%	5,112 $302,000
Q3 2020 Nov 16, 2020	BUY	$35.79 - $48.81 $48,924 - $66,723	1,367 New	1,367 $66,000
Q4 2019 Feb 14, 2020	SELL	$24.56 - $32.8 $3,512 - $4,690	-143 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$30.31 - $53.51 $4,334 - $7,651	143 New	143 $4,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.